23andMe's genetic health report is for three BRCA1 and BRCA2 mutations most commonly found in people of Ashkenazi Jewish descent.
The Artus T. vaginalis QS-RGQ kit is designed for the qualitative detection of Trichomonas vaginalis DNA purified from clinician-collected patient samples.
Exome sequences for individuals with or without sound-color synesthesia in three multi-generational families led to rare variants in axonogenesis genes.
The partners will evaluate the clinical use of the company's TeloView software with DNA sequence analysis in the treatment of lung cancer.
The firm also increased the size of its Series G preferred shares offering and will use the funds to develop tests for guiding the use of cancer immunotherapy.
Chromatin immunoprecipitation sequencing showed divergent H4K16ac histone acetylation patterns in brain samples from young, old, and AD-affected individuals.
Researchers also combined the 121 SNPs they found with pharmacy data to develop a risk score to predict when patients would start lipid-lowering treatments.
Last week, GenomeWeb's readers were most interested in oncologists' worries on CMS's proposed coverage of NGS cancer tests.
The firm provides clinical genomic tests in India and has a research-focused NGS lab in California.
Through the deal, BioDuro has acquired Molecular Response's translational oncology research platform and its biobank of viable tumor specimens.
Noninvasive prenatal screening for trisomies and sub-chromosomal alterations uncovered a fragile site expansion and related deletion present in mothers but not fetuses.
The center will feature five Illumina NovaSeq 6000 gene sequencing systems and offer services to academic and corporate researchers.
The xCas9 variant developed by David Liu and his colleagues recognizes a broad range of PAM sequences and has greater DNA specificity than spCas9.
During a two-year pilot, the Genomic Ascertainment Cohort will collect 10,000 genotypes and make patients available for follow-up exams to confirm predictions.
The GenomeWeb Index outperformed the Nasdaq Biotechnology Index, which lost 5 percent in February, but lost the same amount as the Dow.
By switching off tumor suppressor genes in immunocompetent mice, the team saw that liver cancer developed and killed the mice within four to five months.
The Israeli molecular diagnostics company will use artificial intelligence and phenotypic analysis to increase the diagnostic rate of its genetic tests.
Using data for nearly 59,000 UK Biobank participants, researchers identified genes and pathways involved in heart rate variability, exercise response, and exercise recovery.
The firm said it plans to accelerate the expansion of its test menu through partnerships with pharma and biotech companies.
Perceptive Credit Holdings has agreed to provide the company with the loan, which CareDx said it will use to repay outstanding debt.
The company plans to use the additional funds to introduce new genomics app products within its online store this year.
The firm's CFO said that the timing of revenue recognition on the Beacon carrier screening test prevented Fulgent from recording revenues from the tests in Q4.
Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.
Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.
Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.
In Nature this week: sequenced genomes of five additional Neanderthals, and more.